ConductScience.org, home

Gene · 7150

TOP1: DNA topoisomerase I

11 sourcesgene-search-2026-11-11-0.1.0

Download JSON
Cite this record

ConductScience Library. TOP1: DNA topoisomerase I. Genes, record 7150. Release gene-search-2026-11-11-0.1.0, 11 Nov 2026. https://conductscience.org/library/genes/7150

On this page

Gene

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

Symbol
TOP1
HGNC
Name
DNA topoisomerase I
HGNC
NCBI Gene ID
7150
NCBI Gene
HGNC ID
HGNC:11986
HGNC
Ensembl
ENSG00000198900
NCBI Gene
Aliases
TOPI
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P11387DNA topoisomerase 176515Ensembl, GeneID, HGNC

Source UniProt

Patents82

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4698223 A22026-02-2531P11387Espacenet
JP 2026004568 A2026-01-1467240P11387Espacenet
US 12497601 B22025-12-161243P11387Espacenet
EP 4650780 A22025-11-197879P11387Espacenet
EP 4641201 A22025-10-297981P11387Espacenet
US 12415993 B22025-09-161243P11387Espacenet
JP 2025517969 A2025-06-127981P11387Espacenet
JP 2025517970 A2025-06-127879P11387Espacenet
JP 2025032204 A2025-03-1137464P11387Espacenet
EP 4461818 A22024-11-1337464P11387Espacenet

1 to 10 of 82

See all 82 patents

Drugs26

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
7-ETHYL-10-HYDROXYCAMPTOTHECINCHEMBL837DNA topoisomerase I inhibitorINHIBITORChEMBL
9-AMINOCAMPTOTHECINCHEMBL274070DNA topoisomerase I inhibitorINHIBITORChEMBL
AFELETECANCHEMBL2105857DNA topoisomerase I stabiliserSTABILISERChEMBL
AR-67CHEMBL412309DNA topoisomerase I inhibitorINHIBITORChEMBL
BECATECARINCHEMBL2107313DNA topoisomerase I inhibitorINHIBITORChEMBL
BELOTECANCHEMBL2111084DNA topoisomerase I inhibitorINHIBITORChEMBL
CAMPTOTHECIN-20-O-PROPIONATECHEMBL124162DNA topoisomerase I inhibitorINHIBITORChEMBL
DATOPOTAMAB DERUXTECANCHEMBL4297939DNA topoisomerase I inhibitorINHIBITORChEMBL
DIFLOMOTECANCHEMBL306280DNA topoisomerase I inhibitorINHIBITORChEMBL
EDOTECARINCHEMBL435191DNA topoisomerase I inhibitorINHIBITORChEMBL

1 to 10 of 26

See all 26 drugs

Trials2,417

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07604766TOPOTECANPHASE3ClinicalTrials.gov
NCT07597993TRASTUZUMAB DERUXTECANClinicalTrials.gov
NCT07595913IRINOTECANPHASE3ClinicalTrials.gov
NCT07592819IRINOTECANClinicalTrials.gov
NCT07591831IRINOTECANPHASE2ClinicalTrials.gov
NCT07585279IRINOTECANPHASE2/PHASE3ClinicalTrials.gov
NCT07582887SACITUZUMAB GOVITECANClinicalTrials.gov
NCT07582887TRASTUZUMAB DERUXTECANClinicalTrials.gov
NCT07582887DATOPOTAMAB DERUXTECANClinicalTrials.gov
NCT07578116TRASTUZUMAB DERUXTECANPHASE3ClinicalTrials.gov

1 to 10 of 2,417

See all 2,417 trials

NIH grants2,216

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal year
ZIABC006150DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs1122025
ZIABC006161DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs1112025
P30CA012197Cancer Center Support Grant202025
P30CA016672Cancer Center Support Grant192025
P30CA008748Cancer Center Support Grant182025
ZIABC011078Phase 0-1 Clinical Trials162025
P30CA016056Roswell Park Cancer Center Support Grant152025
P01CA092584Structural Cell Biology of DNA Repair Machines112025
P30CA021765Cancer Center Support Grant (CCSG)112025
P30CA023168Cancer Center Support Grant92025

1 to 10 of 2,216Source NIH's project files

See all 2,216 nih grants

Papers4,103

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42824998PubTator, text miningPubMed
42814835PubTator, text miningPubMed
42807846PubTator, text miningPubMed
42797409PubTator, text miningPubMed
42794684PubTator, text miningPubMed
42789474PubTator, text miningPubMed
42777668PubTator, text miningPubMed
42777032PubTator, text miningPubMed
42768030PubTator, text miningPubMed
42755553PubTator, text miningPubMed

1 to 10 of 4,103

See all 4,103 papers

Sources 11

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNone stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GeneNone named. Public domain as US government information
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/7150

GET https://conductscience.org/api/genes/v1/7150/patents?page=2